Aeterna Zentaris Issues Notice of Meeting and Record Date

TL;DR

Aeterna Zentaris filed a 6-K on May 14th, announcing a Notice of Meeting and Record Date issued May 9th.

AI Summary

Aeterna Zentaris Inc. filed a Form 6-K on May 14, 2024, reporting its activities for May 2024. On May 9, 2024, the company issued a Notice of Meeting and Record Date to NASDAQ and Canadian Securities Regulatory Authorities, with copies attached as exhibits.

Why It Matters

This filing indicates upcoming corporate actions or shareholder events that could impact the company's strategic direction or stock performance.

Risk Assessment

Risk Level: low — This is a routine filing providing notice of a meeting, not indicating significant financial changes or operational risks.

Key Players & Entities

• Aeterna Zentaris Inc. (company) — Filer of the report
• NASDAQ (company) — Recipient of the Notice of Meeting
• Canadian Securities Regulatory Authorities (company) — Recipient of the Notice of Meeting
• May 9, 2024 (date) — Date the Notice of Meeting and Record Date was issued
• May 14, 2024 (date) — Filing date of the Form 6-K

FAQ

Filing Documents

• form6-k.htm (6-K) — 39KB
• ex99-1.htm (EX-99.1) — 7KB
• ex99-2.htm (EX-99.2) — 12KB
• ex99-1_001.jpg (GRAPHIC) — 6KB
• ex99-2_001.jpg (GRAPHIC) — 6KB
• 0001493152-24-018996.txt ( ) — 76KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38064 Aeterna Zentaris Inc. (Translation of registrant’s name into English) c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7, Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F On May 9, 2024, Aeterna Zentaris Inc. (“Aeterna”) issued a Notice of Meeting and Record Date to NASDAQ and to Canadian Securities Regulatory Authorities. Copies of the Notices of Meeting and Record Date are attached as Exhibits 99.1 and 99.2 and are incorporated herein by reference. This report on Form 6-K and Exhibits 99.1 and 99.2 included with this report on Form 6-K are hereby incorporated by reference into Aeterna’s Registration Statements on Forms S-8 (No. 333-224737, No. 333-210561 and No. 333-200834) and Form F-3 (No. 333-254680) and shall be deemed to be a part thereof from the date on which this Report on Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished. This report on Form 6-K, including the exhibits attached hereto and incorporated herein by reference, and the information contained herein and therein are not, and do not, constitute an offer to sell any securities or a solicitation of an offer to buy any securities in the United States or any other state or jurisdiction. No sale of securities or solicitation of an offer to buy any securities will be made in the United States or in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful absent registration or qualification under the securities laws thereof. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from Aeterna that will contain detailed information about Aeterna and its management, as well as financial statements. Aeterna has filed a Registration Statement on Form F-1 (including a prospectus) (File No. 333-277115) (the “Form F-1 Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) for the issuance of common share purchase warrants and common shares issuable upon exercise thereof in connection with the previously announced Plan of Arrangement pursuant to which Aeterna will combine with Ceapro Inc. (“Ceapro”), but the Form F-1 Registration Statement has not yet become effective. The common share purchase warrants and common shares issuable upon the exercise thereof may not be sold nor may offers to buy them be accepted prior to the time the Form F-1 Registration Statement becomes effective. Before you invest in any Aeterna common shares, you should read the prospectus in the Form F-1 Registration Statement and the other documents incorporated by reference therein for more complete information about Aeterna, Ceapro, the Plan of Arrangement and the common share purchase warrant offering. You may get copies of the Form F-1 Registration Statement for free by visiting EDGAR on the SEC website at www.sec.gov or at SEDAR+ at www.sedarplus.ca. Alternatively, you may obtain copies of them by contacting the following: Media Contact Joel Shaffer FGS Longview joel.shaffer@fgslongview.com 416-670-6468 No Offer or Solicitation This Report on Form 6-K and the exhibits attached hereto and incorporated by reference herein, and the information contained herein and therein are not, and do not, constitute an offer to sell any securities or a solicitation of an offer to buy any securities in the United States or any other state or jurisdiction, nor shall any securities of Aeterna be offered or sold in any jurisdiction in which such an offer, solicitation or sale would be unlawful. Neither the SEC nor any state securities commission has approved or disapproved of the transactions described herein or determined if this communication is truthful or complete. Any representation to the contrary is a criminal offense. You should not construe the contents of this Report on Form 6-K or the exhibit attached hereto and incorporated herein by reference as legal, tax, accounting or investment advice or a recommendation. You should consult your own counsel and tax and financial advisors as to legal and related matters concerning the matters described herein. Forward-Looking The information in this Report on Form 6-K and the exhibits attached hereto and incorporated herein by reference include forward-looking Act of 1933, as amended, and Section 21E of the U.S. Securities Excha

View Full Filing

View this 6-K filing on SEC EDGAR